SLC2A1 and perineurioma: In the subgroup analysis, which included 50 cases where three markers (EMA, GLUT-1, and claudin-1) were used in all samples, the results showed that EMA was positive in 84%, GLUT-1 in 94%, and claudin-1 in 88% of GI perineuriomas.